NO991589L - Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler - Google Patents

Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler

Info

Publication number
NO991589L
NO991589L NO991589A NO991589A NO991589L NO 991589 L NO991589 L NO 991589L NO 991589 A NO991589 A NO 991589A NO 991589 A NO991589 A NO 991589A NO 991589 L NO991589 L NO 991589L
Authority
NO
Norway
Prior art keywords
therapeutic agents
novel
preparation
methods
swainsonine
Prior art date
Application number
NO991589A
Other languages
English (en)
Other versions
NO991589D0 (no
Inventor
Rajan Shah
Jeremy Carver
Jose Marino-Albernas
Igor Tvaroska
Francois Tropper
James Dennis
Original Assignee
Glycodesign Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycodesign Inc filed Critical Glycodesign Inc
Publication of NO991589D0 publication Critical patent/NO991589D0/no
Publication of NO991589L publication Critical patent/NO991589L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Oppfinnelsen angår nye 3-, 5- og/eller 6-swainsonin-analoger, fremgangsmåter for deres fremstilling og anvendelse av dem som terapeutiske midler. Oppfinnelsen angår også farmasøytiske preparater inneholdende forbindelsene og anvendelse av dem som terapeutiske midler.
NO991589A 1996-10-01 1999-03-31 Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler NO991589L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2779196P 1996-10-01 1996-10-01
US2758596P 1996-10-03 1996-10-03
PCT/CA1997/000714 WO1998014446A1 (en) 1996-10-01 1997-10-01 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents

Publications (2)

Publication Number Publication Date
NO991589D0 NO991589D0 (no) 1999-03-31
NO991589L true NO991589L (no) 1999-04-06

Family

ID=26702665

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991589A NO991589L (no) 1996-10-01 1999-03-31 Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler

Country Status (8)

Country Link
US (3) US6048870A (no)
EP (1) EP0934318A1 (no)
JP (1) JP2001501213A (no)
CN (1) CN1251588A (no)
AU (1) AU736668B2 (no)
CA (1) CA2267412A1 (no)
NO (1) NO991589L (no)
WO (1) WO1998014446A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014445A2 (en) * 1996-10-03 1998-04-09 Glycodesign Inc. Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
WO1999007366A1 (en) * 1997-08-06 1999-02-18 The Regents Of The University Of Michigan Swainsonine derivatives and methods for preparing the same
WO1999021858A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts
US6670374B1 (en) 2002-06-11 2003-12-30 The United States Of America As Represented By The Secretary Of Agriculture Swainsonine compounds as inhibitors of toxin receptor expression
US7022844B2 (en) 2002-09-21 2006-04-04 Honeywell International Inc. Amide-based compounds, production, recovery, purification and uses thereof
EP1656140A4 (en) * 2003-08-13 2009-03-04 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
WO2022197564A1 (en) * 2021-03-16 2022-09-22 Academia Sinica Polyhydroxylated indolizidine and pyrrolizidine derivatives and uses thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274202A (en) * 1963-04-02 1966-09-20 Mcneilab Inc Certain octohydro-3-oxo-indolizines
DE2846880A1 (de) * 1978-03-22 1979-10-04 Hokuriku Pharmaceutical Substituierte chinolizidin- und indolizidinmethanolderivate, verfahren zur herstellung derselben und arzneimittel, welche diese enthalten
EP0036269A1 (en) * 1980-03-15 1981-09-23 Beecham Group Plc Substituted benzamides
JPS5973519A (ja) * 1982-09-17 1984-04-25 Fujisawa Pharmaceut Co Ltd スワインソニンの製造法およびそれを含む免疫調整剤
JPS6016680A (ja) * 1983-07-05 1985-01-28 株式会社堀場製作所 電気錠の赤外線式開錠装置
JPS60193986A (ja) * 1984-03-14 1985-10-02 Fujisawa Pharmaceut Co Ltd スワインソニン異性体およびその製造方法、並びに免疫調整剤
JPS60218389A (ja) * 1984-04-13 1985-11-01 Tetsuo Suami スワインソニンの製造方法
DE3507019A1 (de) * 1985-02-28 1986-08-28 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
JPS61227566A (ja) * 1985-04-01 1986-10-09 Fujisawa Pharmaceut Co Ltd スワインソニンおよび関連化合物の合成法
JPS61277685A (ja) * 1985-05-31 1986-12-08 Fujisawa Pharmaceut Co Ltd 新規インドリジジン誘導体、その製造法およびそれを含有する組成物
US4837237A (en) * 1985-07-09 1989-06-06 Fred Hutchinson Cancer Research Center Therapy using glucosidase processing inhibitors
EP0252962B1 (en) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
US4857315A (en) * 1986-09-29 1989-08-15 Mount Sinai Hospital Corporation Compositions containing golgi alpha-mannosidase II inhibitors
US4792558A (en) * 1987-05-29 1988-12-20 Merrell Dow Pharmaceuticals Inc. Castanospermine for inhibiting tumor metastasis
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity
WO1990006311A1 (en) * 1988-11-29 1990-06-14 Vanderbilt University Synthesis of (-)-swainsonine and intermediate compounds employed in such synthesis
US4894388A (en) * 1988-12-22 1990-01-16 Monsanto Company Glycosidase inhibitors and use thereof
US5021427A (en) * 1988-12-23 1991-06-04 The Board Of Regents, The University Of Texas System Novel pyrrolizidine alkaloid
US5075457A (en) * 1989-10-20 1991-12-24 Monsanto Company Synthesis of swainsonine and analogs thereof
US5023340A (en) * 1989-10-20 1991-06-11 Monsanto Company Pyrrolizioines and synthesis thereof
US4996329A (en) * 1989-10-20 1991-02-26 Monsanto Company Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and a process for their preparation
US5041555A (en) * 1989-10-20 1991-08-20 Monsanto Company Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and preparation thereof
US5075448A (en) * 1989-10-20 1991-12-24 Monsanto Company Synthesis of swainsonine and analogs thereof
US5240707A (en) * 1990-04-12 1993-08-31 Merrell Dow Pharma Alpha-mannosidase and fucosidase inhibitors
CA2040058C (en) * 1990-04-12 2001-10-23 Robert A. Farr Alpha-mannosidase and fucosidase inhibitors
US5187279A (en) * 1990-07-27 1993-02-16 Cha Jin K Synthesis of (-) swainsonine and intermediate compounds employed in such synthesis
US5288875A (en) * 1991-08-14 1994-02-22 Cha Jin K Synthesis of (-)-swainsonine and intermediate compounds employed in such synthesis
GB9026271D0 (en) * 1990-12-03 1991-01-16 Alphey Thomas J W Control of parasitic nematodes(a)
AU660641B2 (en) * 1991-01-10 1995-07-06 Merrell Dow Pharmaceuticals Inc. Novel glucohydrolase inhibitors useful as antidiabetic agents
US5272070A (en) * 1991-03-08 1993-12-21 Board Of Regents, The University Of Texas System Method for the preparation of cell lines producing Man3 GlcNac 2 asparagine-linked gylcans and cell lines produced thereby
US5552398A (en) * 1991-09-12 1996-09-03 Smithkline Beecham P.L.C. Azabicyclic compounds as 5-HT4 receptor antagonists
US5262425A (en) * 1991-09-18 1993-11-16 Merrell Dow Pharmaceuticals Inc. α-mannosidase inhibitors
US5466809A (en) * 1991-11-06 1995-11-14 Toronto Research Chemicals, Inc. Process for the preparation of immunostimulating swainsonine analogs
GB9318790D0 (en) * 1993-09-10 1993-10-27 Fujisawa Pharmaceutical Co Heterocyclic derivatives
US5543152A (en) * 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents

Also Published As

Publication number Publication date
AU736668B2 (en) 2001-08-02
US20030236229A1 (en) 2003-12-25
US20020099065A1 (en) 2002-07-25
US6048870A (en) 2000-04-11
CN1251588A (zh) 2000-04-26
NO991589D0 (no) 1999-03-31
AU4374397A (en) 1998-04-24
WO1998014446A1 (en) 1998-04-09
CA2267412A1 (en) 1998-04-09
EP0934318A1 (en) 1999-08-11
JP2001501213A (ja) 2001-01-30

Similar Documents

Publication Publication Date Title
DK0813525T3 (da) Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
CO4910163A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
ES2154167A1 (es) Aminoderivados ciclicos antagonistas del receptor ccr-3.
NO20021859D0 (no) Nye digosakkarider, deres fremstilling samt farmasöytiske preparater
MX9702865A (es) Agentes estrogenicos.
DK0922045T3 (da) Bicykliske pyrimidinderivater og deres anvendelse som antikoagulanter
NO305596B1 (no) 1-(2-okso-acetyl)-piperidin-2-karboksylsyrederivater som multi-medikamentresistente sensitivisatorer for kreftceller
EE03253B1 (et) (R)-5-karbamoüül-8-fluoro-3-N,N-diasendatud-amino-3,4-dihüdro-2H-1-bensopüraani d, nende valmistamise protsess ja neid sisaldavad ravimkoostised
DK0929547T3 (da) Benzamidinderivater substitueret af cykliske aminosyrederivater eller cykliske hydroxysyrederivater og deres anvendelse som antikoagulantia
NO883229L (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
NO20050932L (no) 1-pyridin-4-yl-ureaderivater
DK0888271T3 (da) Benzamidinderivater substitueret med aminosyre- og hydroxysyrederivater og deres anvendelse som antikoagulerende midler
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
AU2001232556A1 (en) Pyrimidine compounds and their use as modulators of chemokine receptor activity
DK1124841T3 (da) Substituerede phenylalkenoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler eller diagnosemidler og lægemidler, som indeholder dem
NO991589L (no) Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler
DE60208694D1 (de) Piperidinylmorpholinylderivate als modulatoren der aktivität des chemokinrezeptors
ATE253359T1 (de) Antithrombotische mittel
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
NO20012428L (no) Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer
NO995685L (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
MXPA03008801A (es) Aril oxima-piperazinas utiles como antagonistas de ccr5.
SE9904128D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application